Treatment of Group B Streptococcus UTI in a 67-Year-Old Female
Treat this symptomatic Group B Streptococcus UTI with oral amoxicillin 500 mg every 8 hours for 5-7 days, or alternatively ampicillin if oral therapy is not tolerated.
First-Line Treatment Approach
For this mild, symptomatic GBS urinary tract infection in an older adult female, penicillin-based antibiotics remain the treatment of choice due to universal susceptibility of GBS to penicillin and ampicillin. While the available guidelines focus primarily on perinatal GBS prophylaxis 1, 2, 1, the principles of GBS susceptibility and treatment recommendations translate directly to UTI management.
Recommended Antibiotic Regimens:
Primary option:
- Amoxicillin 500 mg orally every 8 hours for 5-7 days (preferred for outpatient oral therapy)
- Ampicillin 500 mg orally every 6 hours for 5-7 days (alternative)
For penicillin-allergic patients:
- If no history of anaphylaxis: Cefazolin or first-generation cephalosporin
- If high-risk penicillin allergy (anaphylaxis, angioedema, respiratory distress): Vancomycin (requires IV administration) 1
Clinical Reasoning
GBS is a well-documented urinary pathogen in nonpregnant adults, particularly in elderly women with underlying conditions 3, 4. Research shows that GBS accounts for approximately 2% of positive urine cultures in nonpregnant adults, with 85% occurring in women and 95% having at least one underlying condition 4. The infection can manifest as either upper or lower tract disease with equal frequency (37-38% each) 4.
Key considerations for this patient:
- Age 67 places her at higher risk for invasive GBS disease, which has the highest incidence in adults over 60 years 3
- Symptomatic infection requires treatment (unlike asymptomatic bacteriuria, which should not be treated) 5, 6, 7
- GBS shows universal susceptibility to penicillin and ampicillin, making these narrow-spectrum agents ideal 3, 4
Important Caveats and Pitfalls
Do Not Confuse with Asymptomatic Bacteriuria
Asymptomatic bacteriuria should NOT be treated in nonpregnant women, even elderly patients 5, 6, 7. Treatment of ASB increases antibiotic resistance and provides no clinical benefit. Only treat when acute UTI symptoms are present (dysuria, frequency, urgency, suprapubic pain).
Screen for Underlying Urinary Tract Abnormalities
The presence of GBS bacteriuria signals a need to evaluate for urinary tract abnormalities 4. In one study, 60% of patients with GBS UTI had urinary tract abnormalities and 27% had chronic renal failure 4. Consider:
- Renal ultrasound if recurrent infections occur
- Assessment for urinary retention or incomplete bladder emptying
- Evaluation of diabetes mellitus status (common comorbidity)
Antibiotic Resistance Patterns
Recent data shows concerning multidrug resistance in GBS UTI isolates, with 33.6% being MDR 8. However, no resistance to ampicillin or penicillin has been detected 8, 9. Resistance is primarily to:
- Tetracycline (81.5%)
- Azithromycin (44.5%)
- Erythromycin (36.3%)
- Clindamycin (26%)
Therefore, avoid macrolides and tetracyclines for GBS UTI treatment 8, 9.
Treatment Duration
5-7 days of therapy is appropriate for uncomplicated lower UTI in women 6, 10. If symptoms suggest upper tract involvement (fever, flank pain, systemic symptoms), extend to 7-10 days and consider initial parenteral therapy if severe.
When to Reassess
- If symptoms do not improve within 48-72 hours, obtain repeat urine culture
- Consider imaging if pyelonephritis is suspected
- Poor clinical outcome occurs in 18% of GBS UTI cases despite treatment, necessitating close follow-up 4
Comparison to E. coli UTI
Notably, GBS UTIs progress to pyelonephritis at markedly lower rates than E. coli (1.1% vs 15.6%) 11, suggesting that uncomplicated GBS cystitis may have a more benign course. However, this should not diminish the importance of appropriate treatment in symptomatic patients.